Puey-Ling Chia - Search Results

Year	Number of Results
2014	1
2015	1
2016	4
2017	1
2018	2
2019	2
2020	4
2021	2
2022	2
2023	3
2024	0

1

Management of HER2 alterations in non-small cell lung cancer - The past, present, and future.

Nützinger J, Bum Lee J, Li Low J, Ling Chia P, Talisa Wijaya S, Chul Cho B, Min Lim S, Soo RA. Nützinger J, et al. Among authors: ling chia p. Lung Cancer. 2023 Dec;186:107385. doi: 10.1016/j.lungcan.2023.107385. Epub 2023 Sep 28. Lung Cancer. 2023. PMID: 37813015 Review.

2

Lung Cancer in Singapore.

Ang YLE, Chia PL, Chua KLM, Devanand A, Leong CN, Liew CJY, Ong BH, Samol J, Seet JE, Tam JKC, Tan DSW, Teo LLS, Soo RA. Ang YLE, et al. Among authors: chia pl. J Thorac Oncol. 2021 Jun;16(6):906-911. doi: 10.1016/j.jtho.2020.11.020. J Thorac Oncol. 2021. PMID: 34034887 Free article. No abstract available.

3

Resectable non-small cell lung cancer: an evolving landscape.

Loh J, Wijaya ST, Sooi K, Chia PL, Soo RA. Loh J, et al. Among authors: chia pl. Transl Lung Cancer Res. 2022 Jul;11(7):1241-1246. doi: 10.21037/tlcr-22-520. Transl Lung Cancer Res. 2022. PMID: 35958327 Free PMC article. No abstract available.

4

Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma.

Chia PL, Scott AM, John T. Chia PL, et al. Expert Opin Drug Deliv. 2019 Apr;16(4):441-451. doi: 10.1080/17425247.2019.1598374. Epub 2019 Apr 18. Expert Opin Drug Deliv. 2019. PMID: 30916586 Review.

5

Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer.

Loh J, Low JL, Sachdeva M, Low PQ, Wong RSJ, Huang Y, Chia PL, Soo RA. Loh J, et al. Among authors: chia pl. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(9):913-926. doi: 10.1080/14737140.2023.2245140. Epub 2023 Aug 13. Expert Rev Anticancer Ther. 2023. PMID: 37551698 Review.

6

Current and Evolving Methods to Visualize Biological Data in Cancer Research.

Chia PL, Gedye C, Boutros PC, Wheatley-Price P, John T. Chia PL, et al. J Natl Cancer Inst. 2016 May 31;108(8):djw031. doi: 10.1093/jnci/djw031. Print 2016 Aug. J Natl Cancer Inst. 2016. PMID: 27245079 Free PMC article. Review.

7

Editorial Comment to Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.

Leow JJ, Yong DZ, Chia PL. Leow JJ, et al. Among authors: chia pl. Int J Urol. 2022 Mar;29(3):205. doi: 10.1111/iju.14818. Epub 2022 Feb 10. Int J Urol. 2022. PMID: 35144319 No abstract available.

8

Targeting the vasculature: anti-angiogenic agents for malignant mesothelioma.

Chia PL, Russell PA, Scott AM, John T. Chia PL, et al. Expert Rev Anticancer Ther. 2016 Dec;16(12):1235-1245. doi: 10.1080/14737140.2016.1244008. Epub 2016 Oct 12. Expert Rev Anticancer Ther. 2016. PMID: 27696931 Review.

9

Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.

Chia PL, Mitchell P, Dobrovic A, John T. Chia PL, et al. Clin Epidemiol. 2014 Nov 20;6:423-32. doi: 10.2147/CLEP.S69718. eCollection 2014. Clin Epidemiol. 2014. PMID: 25429239 Free PMC article. Review.

10

Vortex Keratopathy Presumed Secondary to AZD9291.

Chia PL, John T. Chia PL, et al. J Thorac Oncol. 2015 Dec;10(12):1807-8. doi: 10.1097/JTO.0000000000000634. J Thorac Oncol. 2015. PMID: 26709481 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year